1 of interventions to reduce use of seclusion. Although studies reviewed were conducted in adult and child settings, the authors did not differentiate the developmental needs between these patient populations.
The determinants of emotional distress and aggression may differ between children and adults. In adult psychiatric units, aggression is frequently associated with psychosis. Seclusion may reduce staff injury but increases patient distress.
2 In contrast, aggression is typically the most common reason for referral to child psychiatric units. Underlying diagnoses include disruptive behavioural and developmental disorders, and are complicated by high rates of abuse and neglect.
3 Admission goals may include learning prosocial behaviour, necessitating use of behavioural management. Community-based studies indicate that parent management training, using contingency reinforcement and consequences such as 'closed time-out' , are effective in reducing aggressive behaviours. 4 Seclusion may function similarly to time-out, in that it can take the child away from a situation reinforcing negative behaviour and it encourages the child to self-regulate.
We agree with Gaskin et al that more evidence is needed to guide use of such interventions. We draw readers' attention to a recent study reporting reductions in aggression in a child and adolescent in-patient unit, following the introduction of a behavioural management programme. 3 The intervention incorporated staff training, contingency management and promoted use of less restrictive interventions. In keeping with current practice parameters, 5 if a restrictive intervention was required the preferred intervention was a form of seclusion. This intervention led to a significant reduction in aggressive incidents and injuries to staff and patients. Although the number of episodes of locked interventions did not decrease, there was a significant reduction in the duration of time patients spent in seclusion and a reduction in physical restraint. These outcomes were achieved without reducing admission numbers, changing the types of admissions, increasing staff costs, or increasing utilisation of medication as needed.
We concur with Gaskin et al that seclusion may exert countertherapeutic effects, and that effective alternatives should be identified.
1 However, we remain open to the possibility that predictable, time-limited locked interventions may have therapeutic effects when used within a broader behavioural management programme in young patient populations. In addition, the ultimate goal of interventions in this area should emphasise reducing the demand for seclusion, rather than just the use of seclusion per se. We need to acknowledge that some aspects of the in-patient environment can contribute to patient distress and seek to optimise the therapeutic effects of the in-patient milieu. Protocols for use of seclusion and for reduction in demand for seclusion need to be incorporated into the developmental needs of the specific patient group. Authors' reply:
Reducing seclusion in psychiatric facilities often involves the coordination of a range of interventions to meet the needs of such organisations and their staff.
1 In their response to our review, Scott & Dean have helpfully highlighted the need to tailor interventions to suit specific facilities through reminding readers of the differing determinants of emotional distress and aggression that are present for children and adults. These differences influence the reasons why children and adults are secluded.
In combining the literature on seclusion reduction initiatives at child, adolescent and adult psychiatric facilities, we do not contend that seclusion practices across these facilities, or the reasons for seclusion, are the same. We did, however, find no meaningful differences in the employment of seclusion reduction interventions between child, adolescent and adult facilities. Many of the interventions we found (e.g. monitoring seclusion episodes, staff education, changing the therapeutic environment) were used equally as often in child psychiatric units as they were in adult facilities.
Although the broad interventions for seclusion reduction appear similar between child and adult psychiatric facilities, the content of each type of intervention is likely to differ between facilities that serve specific populations. For example, staff education conducted at a child psychiatric unit to reduce seclusion may well be different to that provided at an adult psychiatric unit.
Our paper has provided the bare bones of a range of interventions that have been successfully used to reduce seclusion in psychiatric facilities. We welcome further comment, such as that from Scott & Dean, and the publication of seclusion reduction initiatives to help describe the ways in which these interventions can be applied in various types of facilities.
A new spectrum of personality disorders?
Schug et al's article on psychophysiological and behavioural characteristics of individuals with comorbid antisocial personality disorder (ASPD) and schizophrenia-spectrum personality disorder (SSPD) opens the possibility of the existence of a new spectrum of personality disorders. But reading the article with care raises some questions.
First, the community-based study population which was recruited from temporary employment agencies appears to have a prevalence of personality disorder of the order of what we would observe in psychiatric in-patient units.
2 The total prevalence in this study population was 52.4%, which is way beyond the prevalence rate in community-based samples. 3 Conducting studies in such a population could lead to selection bias. By nature, individuals from such samples are more likely to have more severe and complex forms of the disorder. 4 This might explain the high prevalence rate of combined ASPD/SSPD observed in the study. It would have been more interesting to know the number of individuals from this sample who have comorbidity between SSPD and other personality disorders such as narcissistic, histrionic and borderline.
Second, in the psychophysiological and behavioural characteristics of the four study groups I noticed a pattern: the comorbid ASPD/SSPD groups appear at the severe end of the spectrum, where abnormal characteristics are more frequently observed (four out of six characteristics studied in this research, namely self-reported crime and skin conductance frequency, amplitude and arousal) than the control group, which lies at the other end of the spectrum. Individuals in the ASPD and SSPD groups lie on either side of the middle of the spectrum.
A basic structural abnormality in the frontal cortex might cause these individuals to have higher psychiatric comorbidity (not only of ASPD and SSPD) and the abnormal characteristics identified might not be entirely explained by the co-occurrence of these two disorders. The authors have rightly identified that the results could not merely be due to the additive effects of both disorders, but that the increased prevalence of personality disorder in the study population might be due to a common confounder that does not lie on the causal pathway between ASPD/SSPD and abnormality in characteristics. Authors' reply:
We are grateful for thoughtful critical points raised by Drs Sekar and Ganapathy. We agree that the prevalence of personality disorders in our sample is high. This sample was chosen for its elevated rates of ASPD -perhaps attributable to a downward drift in occupational functioning due to antisocial features. It is certainly vulnerable to selection bias for several reasons (among them being the fact that some individuals did not meet inclusion criteria), and the 52.4% personality disorder prevalence rate should not be mistaken for a typical community population base rate, or a general rate applying to other populations (claims which were not made in our paper). Also, the prevalence rates of other individual personality disorders (e.g. narcissistic personality disorder -around 3%) were consistent with general population estimates.
1,2 Additionally, our focus was the characteristics of this ASPD/SSPD group, rather than making any assertions about its prevalence in the general population.
On reading the correspondents' comment about SSPD comorbidity with other personality disorders, we too became intrigued with this possibility and have since conducted further analyses. These revealed, among the other personality disorders, significant SSPD comorbidity only with narcissistic personality disorder. In fact, all three of our sample's individuals with narcissistic personality disorder had comorbid ASPD and SSPD. This additional comorbidity among our ASPD/SSPD group is not surprising, given the problematically high overlap of narcissistic personality disorder with ASPD and other Cluster B disorders, 2, 3 the conceptual link between the narcissistic and antisocial personalities (e.g. Kernberg's 'malignant narcissism'), 3 and the positive correlations observed between narcissistic personality disorder and other antisocial personalities such as psychopathy. 4 We still believe ASPD/SSPD comorbidity to be meaningful, and not an artifact of the sample, as 50% of individuals with comorbid ASPD/SSPD were not characterised by any additional Axis II comorbidity.
We agree that the frontal cortex (specifically the prefrontal cortex) may be a common abnormality and that this needs further investigation. Clearly, additional research is needed on this comorbid group, in both clinical and nonclinical populationsincluding 'unique' community samples such as our own.
Patient choice in psychiatry in low-and middleincome countries
Samele et al 1 have highlighted the implications of patient choice in psychiatry and some of its main challenges. The importance of a patient-oriented approach in psychiatry has even been emphasised in the World Health Report.
2 Patients seem to want more say in their treatment decisions, to receive appropriate information on their condition and make decisions concerning the management of their illness.
3 Psychiatry is a particularly challenging area with regard to this, because mental illness can affect both understanding and decision-making abilities. This topic has significance particularly to low-and middle-income countries such as Sri Lanka. The attitudes of patients and choice of therapy in low-and middle-income countries may differ from those in high-income countries as cultural norms and beliefs play a major role in decision-making. 4 Also, almost all the time, patients depend on the therapist to make decisions regarding their treatment either because they themselves are not knowledgeable enough or they think the therapist knows best. At present, suing by patients is found less frequently in low-and middle-income countries compared with the West, hence therapists are not under pressure when making decisions. This may contribute to the maintenance of the 'therapist-centred' approach in the management of patients in our part of the world. Another reason which makes patient choice less feasible in low-and middle-income countries is the limited number of therapeutic options, owing to lack of resources. This sometimes leads to medications being the only available option although other treatment modalities are indicated for the particular condition. Another factor which might impede patient choice is the lack of a proper mental health act. Some low-and middle-income countries either do not have a mental health act 2 or the existing mental health acts are archaic, were developed during the pre-antipsychotic era and are not at all patient centred. Psychiatrists and policy makers, particularly in low-and middle-income countries, should be aware of these important issues when health plans are made and implemented.
